VRTX - CIK 0000875320
VERTEX PHARMACEUTICALS INC / MA has filed 1,000 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (655 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2024-06-03 | 2024-05-30 |
| Insider sale notice | 144 | 2024-05-31 | - |
| Insider trade | 4 | 2024-05-31 | 2024-05-29 |
| Insider sale notice | 144 | 2024-05-30 | - |
| Insider trade | 4 | 2024-05-30 | 2024-05-28 |
| Insider sale notice | 144 | 2024-05-29 | - |
| Insider trade | 4 | 2024-05-29 | 2024-05-24 |
| Insider sale notice | 144 | 2024-05-28 | - |
| Insider sale notice | 144 | 2024-05-24 | - |
| Insider trade | 4 | 2024-05-24 | 2024-05-22 |
| Insider sale notice | 144 | 2024-05-22 | - |
| Insider trade | 4 | 2024-05-22 | 2024-05-20 |
| Insider sale notice | 144 | 2024-05-20 | - |
| Major company event | 8-K | 2024-05-20 | 2024-05-20 |
| SC TO-T/A | - | 2024-05-20 | - |
| Insider trade | 4 | 2024-05-17 | 2024-05-15 |
| Insider trade | 4 | 2024-05-17 | 2024-05-15 |
| Insider trade | 4 | 2024-05-17 | 2024-05-15 |
| Insider trade | 4 | 2024-05-17 | 2024-05-15 |
| New insider ownership | 3 | 2024-05-17 | 2024-05-15 |
| Insider trade | 4 | 2024-05-16 | 2024-05-14 |
| Insider sale notice | 144 | 2024-05-15 | - |
| Insider sale notice | 144 | 2024-05-15 | - |
| Insider sale notice | 144 | 2024-05-15 | - |
| Major company event | 8-K | 2024-05-15 | 2024-05-15 |
| SC TO-T/A | - | 2024-05-10 | - |
| SC TO-T/A | - | 2024-05-08 | - |
| Quarterly report | 10-Q | 2024-05-07 | 2024-03-31 |
| Major company event | 8-K | 2024-05-06 | 2024-05-06 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider sale notice | 144 | 2024-05-02 | - |
| SC TO-T | - | 2024-04-22 | - |
| Insider trade | 4 | 2024-04-17 | 2024-04-15 |
| Shareholder proxy notice | PX14A6G | 2024-04-16 | - |
| SC TO-C | - | 2024-04-11 | - |
| SC TO-C | - | 2024-04-11 | - |
| Major company event | 8-K | 2024-04-11 | 2024-04-10 |
| Passive ownership stake (update) | SC 13G/A | 2024-04-10 | - |
| SC TO-C | - | 2024-04-10 | - |
| Annual report to shareholders | ARS | 2024-04-04 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-04 | - |
| Proxy statement | DEF 14A | 2024-04-04 | 2023-05-15 |